Comparison of Erector Spinae Plane Block and Intravenous Patient-controlled Analgesia in Percutaneous Nephrolithotomy
Nephrolithiasis, Percutaneous, Analgesia
About this trial
This is an interventional treatment trial for Nephrolithiasis focused on measuring Percutaneous, Nephrolithotomy, Plane Block, Patient-controlled analgesia
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists (ASA) class I-III, Between 18-65 years old, Percutaneous nephrolithotomy surgery, Patients who agreed to participate in the study Exclusion Criteria: Obesity (BMI≥ 35) Coagulopathy Active Infection Drug allergies Pregnancy 65 years and older
Sites / Locations
- Haci Yusuf GUNES
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Group ESP, Erector Spina Plane Block (n= 30)
Group PCA, Patient Controlled Analgesia (n= 30)
After the surgical procedure was completed in patients who underwent general anesthesia, the necessary sterility was provided for the ESPB procedure while the patient was in the lateral position. 1mg/kg 0.5% bupivacaine + 1mg/kg 2% lidocaine was drawn into the same syringe and the volume was completed to 20 ml with normal saline. A linear 10-18 MHz USG probe was placed at the thoracic 7 level (Esaote MyLab 30, Geneva, Italy) in the paramedian plane between two transverse processes. The prepared local anesthetic drug was administered under the guidance of USG.
For patients in the PCA group, 200 mg of tramadol was placed in 100cc of 0.9% NaCl. Set to PCA device. A 50mg loading dose was administered 10 minutes before the patient was extubated. After extubating, a bolus dose of 20 mg was started, with a 30-minute lock-in time, and an infusion dose of 5mg/hour. The 4-hour maximum limit was set to 200 mg.